| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blood Pressure
|
Ortiz, Alberto
|
|
2012
|
34 |
4S |
p. e12-e13
nvt p.
|
artikel
|
| 2 |
Children With Fabry Disease
|
Ramaswami, Uma
|
|
2012
|
34 |
4S |
p. e18-
1 p.
|
artikel
|
| 3 |
Endocrinology
|
Feldt-Rasmussen, Ulla
|
|
2012
|
34 |
4S |
p. e14-
1 p.
|
artikel
|
| 4 |
Fabry International Network
|
De Bare, Lut
|
|
2012
|
34 |
4S |
p. e15-
1 p.
|
artikel
|
| 5 |
Foreword
|
Germain, Dominique P.
|
|
2012
|
34 |
4S |
p. e1-
1 p.
|
artikel
|
| 6 |
How to Assess Kidney Function: Overview
|
Froissart, Marc
|
|
2012
|
34 |
4S |
p. e4-e5
nvt p.
|
artikel
|
| 7 |
How to Stage and Assess the Deterioration of Kidney Function in Children?
|
Svarstad, Einar
|
|
2012
|
34 |
4S |
p. e5-e7
nvt p.
|
artikel
|
| 8 |
Keynote Lecture: Fabry Disease
|
Germain, Dominique P.
|
|
2012
|
34 |
4S |
p. e3-
1 p.
|
artikel
|
| 9 |
Kidney Histology
|
Fogo, Agnes B.
|
|
2012
|
34 |
4S |
p. e11-
1 p.
|
artikel
|
| 10 |
Lysosomal Biology
|
Heales, Simon
|
|
2012
|
34 |
4S |
p. e10-e11
nvt p.
|
artikel
|
| 11 |
Managing Cardiac Complications: Drugs and Devices
|
Weidemann, Frank
|
|
2012
|
34 |
4S |
p. e15-
1 p.
|
artikel
|
| 12 |
Managing Patients With Chronic Kidney Disease
|
Warnock, David G.
|
|
2012
|
34 |
4S |
p. e16-e17
nvt p.
|
artikel
|
| 13 |
Meeting the Current Clinical Management Challenges
|
Waldek, Stephen
|
|
2012
|
34 |
4S |
p. e3-e4
nvt p.
|
artikel
|
| 14 |
Neuropathic Pain
|
Sommer, Claudia
|
|
2012
|
34 |
4S |
p. e17-e18
nvt p.
|
artikel
|
| 15 |
New Techniques for Assessing the Heart (Cardiac Imaging)
|
Schmitt, Matthias
|
|
2012
|
34 |
4S |
p. e7-e8
nvt p.
|
artikel
|
| 16 |
Overlooked Signs and Symptoms: Lung
|
Linhart, Aleš
|
|
2012
|
34 |
4S |
p. e11-e12
nvt p.
|
artikel
|
| 17 |
P13—A Case of Fabry Disease With Unexplained Abdominal Pain
|
Küçükçongar, A.
|
|
2012
|
34 |
4S |
p. e23-e24
nvt p.
|
artikel
|
| 18 |
P18—Agalsidase Alfa and Agalsidase Beta have Similar Effects on Outcomes in Fabry Disease: Results From the Canadian Fabry Disease Initiative
|
West, M.
|
|
2012
|
34 |
4S |
p. e25-
1 p.
|
artikel
|
| 19 |
P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry
|
Feldt-Rasmussen, U.
|
|
2012
|
34 |
4S |
p. e26-
1 p.
|
artikel
|
| 20 |
P26—Anti-CD3 Antibody Reduces AntibodY Formation and Prevents Potentially Fatal Hypersensitivity Reaction in Enzyme-Replacement Therapy for Murine Lysosomal Storage Diseases
|
Ohashi, T.
|
|
2012
|
34 |
4S |
p. e28-
1 p.
|
artikel
|
| 21 |
P15—Cardiovascular Manifestations of Fabry Disease in Mexico
|
Pazarín-Villaseñor, L.
|
|
2012
|
34 |
4S |
p. e24-
1 p.
|
artikel
|
| 22 |
P10—Comprehensive Assessment of Long-Term Enzyme Replacement Therapy in Fabry Disease: The 5-Year Data
|
Baumgärtner, E.K.
|
|
2012
|
34 |
4S |
p. e22-
1 p.
|
artikel
|
| 23 |
P09—Early Onset of Cardiomyopathy Demonstrated by Tissue Doppler Imaging in a Child With Fabry Disease
|
Mignani, R.
|
|
2012
|
34 |
4S |
p. e22-
1 p.
|
artikel
|
| 24 |
P06—Enzyme Replacement Therapy with Agalsidase Beta for Fabry Disease: Importance of the Doses—A Case Report
|
Smelten, N.
|
|
2012
|
34 |
4S |
p. e20-e21
nvt p.
|
artikel
|
| 25 |
Peripheral Blood Cytopenias and Spleen Pathology
|
Oliveira, João Paulo
|
|
2012
|
34 |
4S |
p. e13-e14
nvt p.
|
artikel
|
| 26 |
P03—Excessive Daytime Sleepiness is a Common Symptom in Fabry Disease
|
Duning, T.
|
|
2012
|
34 |
4S |
p. e19-
1 p.
|
artikel
|
| 27 |
P12—Fabry Disease in Latin America: A Report From the Fabry Registry
|
Martins, A.M.
|
|
2012
|
34 |
4S |
p. e23-
1 p.
|
artikel
|
| 28 |
P21—Fabry Disease in Women: Findings From the Fabry Registry
|
Linthorst, G.
|
|
2012
|
34 |
4S |
p. e26-
1 p.
|
artikel
|
| 29 |
P02—Fabry International Network: Fabry Patient Survey
|
Sedal, R.
|
|
2012
|
34 |
4S |
p. e19-
1 p.
|
artikel
|
| 30 |
P17—Importance of Family Screening in Fabry Disease: Reaching the Bottom of the iceberg
|
Koca, S.
|
|
2012
|
34 |
4S |
p. e24-e25
nvt p.
|
artikel
|
| 31 |
P19—Influence of Anti-Agalsidase Antibodies on Clinical Outcomes in the Canadian Fabry Disease Initiative Study
|
West, M.
|
|
2012
|
34 |
4S |
p. e25-
1 p.
|
artikel
|
| 32 |
P25—Late Diagnosis of Fabry Disease with Cardiovascular Manifestations
|
Godenèche, G.
|
|
2012
|
34 |
4S |
p. e27-e28
nvt p.
|
artikel
|
| 33 |
P28—Metabolomic Studies in Fabry Disease
|
Auray-Blais, C.
|
|
2012
|
34 |
4S |
p. e28-
1 p.
|
artikel
|
| 34 |
P11—Natural History of Fabry Disease: Characterization of Symptom Onset in a Turkish Family
|
Bahçebasşi, Z. Bicik
|
|
2012
|
34 |
4S |
p. e22-e23
nvt p.
|
artikel
|
| 35 |
P22—Nephropathy in Fabry Disease with Proteinuria, Minterpreted as Chronic Glomerulonephritis with Subsequent Inadequate Immunosuppressive Therapy
|
Fomin, V.V.
|
|
2012
|
34 |
4S |
p. e26-
1 p.
|
artikel
|
| 36 |
P04—Neurophysiologic Examinations in Patients with Fabry-Anderson Disease
|
Hajas, A.
|
|
2012
|
34 |
4S |
p. e19-e20
nvt p.
|
artikel
|
| 37 |
P23—New Guidelines for the Evaluation and Management of Fabry Disease in Children
|
Tylki-Szymanska, A.
|
|
2012
|
34 |
4S |
p. e27-
1 p.
|
artikel
|
| 38 |
P16—Ophthalmologic Manifestations of Fabry Disease in Mexico
|
Pazarín-Villaseñor, L.
|
|
2012
|
34 |
4S |
p. e24-
1 p.
|
artikel
|
| 39 |
P05—Peripheral Vasculature Involvement in Fabry Patients: Is There any Difference Between Genders?
|
Cabrera, G.
|
|
2012
|
34 |
4S |
p. e20-
1 p.
|
artikel
|
| 40 |
P24—Prognostic Indicators of Renal Disease Progression: Natural History Data From the Fabry Registry
|
Wanner, C.
|
|
2012
|
34 |
4S |
p. e27-
1 p.
|
artikel
|
| 41 |
P08—Quality of Life did not Worsen for 7 Years in Enzyme-Replacement Therapy Recipients with Fabry Disease
|
Kantola, I.
|
|
2012
|
34 |
4S |
p. e21-e22
nvt p.
|
artikel
|
| 42 |
P01—The Fabry International Network
|
De Baere, L.
|
|
2012
|
34 |
4S |
p. e19-
1 p.
|
artikel
|
| 43 |
P27—Uptake of α-Galactosidase a in Human Glomerular Podocytes is Mediated by Various Receptors in Fabry Disease
|
Prabakaran, T.
|
|
2012
|
34 |
4S |
p. e28-
1 p.
|
artikel
|
| 44 |
P07—Ventricular Arrhythmias are the Major Cause of Death in Patients With the Classical Phenotype of Fabry Disease
|
Niemann, M.
|
|
2012
|
34 |
4S |
p. e21-
1 p.
|
artikel
|
| 45 |
Review of Brain-Assessment Techniques
|
Politei, Juan
|
|
2012
|
34 |
4S |
p. e9-
1 p.
|
artikel
|
| 46 |
Stroke: Prevention and Management
|
Tyrrell, Pippa
|
|
2012
|
34 |
4S |
p. e17-
1 p.
|
artikel
|
| 47 |
The Vessels: Focusing on the Aorta
|
Mousseaux, Elie
|
|
2012
|
34 |
4S |
p. e8-e9
nvt p.
|
artikel
|
| 48 |
Title Page
|
|
|
2012
|
34 |
4S |
p. A1-
1 p.
|
artikel
|
| 49 |
White Matter Lesions and Brain Vessels
|
Fellgiebel, Andreas
|
|
2012
|
34 |
4S |
p. e9-e10
nvt p.
|
artikel
|
Tijdschrift beschrijving